-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
REGENERX BIOPHARMACEUTICALS INC quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q2 2020 to Q1 2023.
- REGENERX BIOPHARMACEUTICALS INC Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Mar 2023 was $40,894.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)